Vascular endothelial growth factor concentration as a predictive marker: ready for primetime?
Peter A
PA
Kavsak
Hal
H
Hirte
Sebastien J
SJ
Hotte
D014408:Biomarkers, Tumor / Q000097:blood*; D001774:Blood Chemical Analysis / Q000379:methods*; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use; D011237:Predictive Value of Tests; D011799:Quinazolines / Q000627:therapeutic use; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors / Q000097:blood*; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D010880:Piperidines; D011799:Quinazolines; D040262:Receptors, Vascular Endothelial Growth Factor; C452423:vandetanib